Finasteride vs Dutasteride: Which Works Better?

Finasteride and dutasteride are both 5-alpha reductase inhibitors. Both block the enzyme that converts testosterone to DHT, the hormone responsible for male pattern hair loss. On that shared mechanism they look similar, but there are meaningful differences in which enzyme they target, how much DHT they suppress, and what the FDA has approved them for. The two medications are not interchangeable, and the choice between them deserves a real clinical conversation.

The two enzymes and why they matter

5-alpha reductase exists in two clinically relevant forms. Type I is expressed primarily in the liver, skin, and sebaceous glands. Type II is expressed primarily in the hair follicle, prostate, and genitalia. Both types convert testosterone to DHT, but their tissue distribution is different.

Finasteride selectively inhibits type II 5-alpha reductase. That is why it was originally developed for prostate indications (where type II dominates) and subsequently approved for male pattern hair loss (where type II also dominates in the hair follicle). Dutasteride inhibits both type I and type II. The dual inhibition produces more complete DHT suppression across tissues.

How much DHT each medication suppresses

Finasteride 1mg daily reduces serum DHT by approximately 60 to 70 percent. Dutasteride 0.5mg daily reduces serum DHT by approximately 90 percent. That is a meaningful difference, and in clinical trials comparing the two for hair loss, dutasteride tends to produce somewhat greater hair count increases and more pronounced improvements in Norwood grade.

That said, the marginal benefit of dutasteride over finasteride for most patients is modest in absolute terms. Finasteride produces stabilization in roughly 90 percent of men at 12 to 24 months of consistent use, with regrowth in a majority. Going from finasteride-level response to dutasteride-level response is often a refinement rather than a transformation.

FDA status and clinical use

Finasteride 1mg is FDA-approved specifically for male pattern hair loss (sold as Propecia or generic). This is the standard first-line oral treatment for male pattern baldness. Dutasteride is FDA-approved for benign prostatic hyperplasia (sold as Avodart) but not for hair loss in the United States, though it is approved for hair loss in some other countries (such as South Korea and Japan).

In the United States, dutasteride for hair loss is therefore prescribed off-label. Off-label prescribing is common and legitimate in medicine, but it is more appropriate when there is a specific clinical reason to prefer dutasteride over finasteride. Typically that reason is inadequate response to finasteride after 12 to 18 months of consistent use.

Side-effect profile

Both medications share a similar side-effect profile centered on sexual side effects (reduced libido, erectile changes, decreased ejaculatory volume) in a small percentage of men. The reported incidence in clinical trials is roughly 1 to 4 percent for each. Dutasteride's broader DHT suppression does not produce dramatically more side effects in most trials, though individual reports vary.

Dutasteride has a substantially longer half-life than finasteride, roughly 5 weeks compared to 6 to 8 hours. This matters if you want to stop the medication and have effects wash out quickly. Finasteride clears the system in days. Dutasteride takes months. Both medications affect PSA interpretation for prostate cancer screening, and your physician should be aware if you are taking either before a PSA test.

When dutasteride makes sense

The clinical case for dutasteride is strongest in two scenarios. First, men who have been on finasteride for 12 to 18 months and are not achieving the response they hoped for (continued progression or inadequate regrowth). Second, men with particularly aggressive or rapid hair loss who want the fullest possible DHT suppression from the start. In both cases, the decision should be made with a physician who has reviewed your specific pattern and history.

For most men starting treatment, finasteride is the right first-line choice: FDA-approved, extensively studied, effective, and with a shorter washout if you need to stop. Starting with finasteride and considering dutasteride only if response is inadequate is the standard and reasonable approach.

What Eros MD typically prescribes

Eros MD prescribes finasteride 1mg daily as the first-line oral DHT-blocking treatment for male pattern hair loss. For men with inadequate response after appropriate duration, or for patients with specific clinical indications, dutasteride can be considered. The right decision is based on your response, your goals, and a physician evaluation of the full picture.